Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adeno-associated virus vector

Gene Therapy volume 6, pages 1175–1178 (1999)Cite this article

Abstract

Mucopolysaccharidosis type VII (MPS VII) is an inherited lysosomal storage disease caused by insufficient β-glucuronidase (GUS). To provide gene therapy in a mutant mouse model of this disease, we have used a recombinant adeno-associated virus (rAAV) vector to deliver GUS cDNA to a variety of tissues. Although intravenous administration of vector produced therapeutic levels of GUS in the liver, delivery to the brain was inadequate. To improve delivery to the brain intrathecal injection of the vector into the cerebrospinal fluid was employed. This route of administration to either neonatal or adult mutant mice resulted in therapeutic levels of GUS in the brain and the elimination of storage granules in brain tissue.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Neufeld EF, Muenzer J . The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Bases of Inherited Disease McGraw-Hill: New York 1995; pp 2465–2494

    Google Scholar 

  2. Sly WS, Quinton BA, McAlister WH, Rimoin DL . Beta glucuronidase deficiency: report of clinical, radiologic and biochemical features of mucopolysaccharidosis J Pediatr 1973 82: 249–257

    Article  CAS  Google Scholar 

  3. Birkenmeier EH et al. Murine mucopolysaccharidosis type VII: characterization of a mouse with β-glucuronidase deficiency J Clin Invest 1989 83: 1258–1266

    Article  CAS  Google Scholar 

  4. Watson G et al. Treatment of lysosomal storage disease in MPS VII mice using a recombinant adeno-associated virus GeneTherapy 1998 5: 1642–1649

    CAS  Google Scholar 

  5. Taylor RM, Wolfe JH . Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of β-glucuronidase Nature Med 1997 3: 771–774

    Article  CAS  Google Scholar 

  6. Sly WS, Vogler C . Gene therapy for lysosomal storage disease: a no-brainer? Nature Med 1997 3: 719–720

    Article  CAS  Google Scholar 

  7. Ohashi T et al. Adenovirus-mediated gene transfer and expression of human β-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice Proc Natl Acad Sci USA 1997 94: 1287–1292

    Article  CAS  Google Scholar 

  8. Vogler C et al. Enzyme replacement with recombinant β-glucuronidase in the newborn mucopolysaccharidosis type VII mouse Pediatr Res 1993 34: 837–840

    Article  CAS  Google Scholar 

  9. O’Connor LH et al. Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function J Clin Invest 1998 101: 1394–1400

    Article  Google Scholar 

  10. Peel AL et al. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters Gene Therapy 1997 4: 16–24

    Article  CAS  Google Scholar 

  11. Sands MS, Birkenmeier EH . A single base-pair deletion in the β-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII Proc Natl Acad Sci USA 1993 90: 6567–6571

    Article  CAS  Google Scholar 

  12. Matsushita T et al. Adeno-associated virus vectors can be efficiently produced without helper virus Gene Therapy 1998 5: 938–945

    Article  CAS  Google Scholar 

  13. Owerbach D, Lusis AJ . Phenobarbital induction of egasyn: availability of egasyn in vivo determines glucuronidase binding to membrane Biochem Biophys Res Commun 1976 69: 628–634

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank Avigen Inc, and particularly Dr Greg Podsakoff for encouragement and support. This work was financially supported in part by NIH grant DK43319 and the CHORI Endowment Fund.

Author information

Authors and Affiliations

  1. Children’s Hospital Oakland Research Institute, Oakland, CA, USA

    S S Elliger, C A Elliger, C P Aguilar & G L Watson

  2. Berkeley Antibody Co, Berkeley, CA, USA

    N R Raju

Authors
  1. S S Elliger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C A Elliger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C P Aguilar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N R Raju
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G L Watson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elliger, S., Elliger, C., Aguilar, C. et al. Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adeno-associated virus vector. Gene Ther 6, 1175–1178 (1999). https://doi.org/10.1038/sj.gt.3300931

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300931

Keywords

This article is cited by

Search

Advanced search

Quick links